Kathleen M Mortimer

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Risk evaluation and mitigation strategies (REMS), as mandated by the US Food and Drug Administration (FDA) for medications with the potential for harm, are increasingly incorporating rigid protocols for patient evaluation, but little is known about compliance with these programs. Despite the inherent limitations, data on administrative claims may(More)
Abbreviation: TMLE, targeted maximum likelihood estimator. We thank Vansteelandt and Keiding (1) for their commentary on our article (2), in which we implemented G-computation , a maximum likelihood-based substitution estimator of the G-formula. The goals of that article included 1) translating G-computation into the applied epidemiology literature by using(More)
  • 1